View Older Stories View More Recent Stories

May 29, 2024 07:58AM BMO Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
May 22, 2024 07:28AM BMO Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
May 17, 2024 07:38AM BMO Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
May 6, 2022 06:54AM Ionis Pharmaceuticals (IONS) Reports Strong 1Q, Eplontersen PN Data Soon - BMO Capital
Feb 24, 2021 03:30PM Ionis Pharmaceuticals (IONS) PT Raised to $90 at BMO Capital, Following Earnings
Feb 3, 2021 11:42AM Ionis Pharmaceuticals (IONS) PT Trimmed to $85 at BMO Capital
Jan 30, 2020 11:13AM BMO Capital Maintains Rating, PT on Ionis Pharmaceuticals (IONS) Despite Lower Spinraza Sales
Jul 23, 2019 11:50AM Ionis Pharmaceuticals (IONS) PT Lowered to $95 at BMO Capital, Lowers Spinraza Estimates
Apr 22, 2019 07:33AM Ionis Pharmaceuticals (IONS) PT Raised to $96 at BMO Capital
Feb 28, 2019 07:31AM Ionis Pharmaceuticals (IONS) PT Raised to $82 at BMO Capital
Apr 24, 2018 12:04PM Ionis Pharmaceuticals (IONS) PT Lowered to $74 at BMO Capital
Apr 20, 2018 09:51AM Ionis Pharmaceuticals (IONS) PT Raised to $75 at BMO Capital on Expanded Biogen Deal
Dec 7, 2017 07:00AM Ionis Pharmaceuticals to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
Sep 29, 2017 11:53AM Ionis Pharmaceuticals (IONS) Selling Pressure 'Unwarranted' - BMO
Aug 14, 2017 08:20AM Ionis Pharmaceuticals (IONS) PT Raised to $69 at BMO Capital on 2Q; 'Tempering Better Economics Given Uncertainty Risk'
Jul 25, 2017 01:51PM Ionis Pharmaceuticals (IONS) PT Raised to $67 at BMO Capital; Buy on Weakness
Jul 25, 2017 07:50AM Ionis (IONS) Partner Biogen Reports Blow-Out Spinraza Sales - BMO Capital
Jul 19, 2017 04:19PM Akcea Therapeutics (AKCA) Closes IPO, Reports $50M Private Placement with Novartis Pharma (NVS)
Jul 19, 2017 04:15PM Akcea Therapeutics Announces Closing of Initial Public Offering
Jul 13, 2017 08:25PM Akcea Therapeutics Announces Pricing of Initial Public Offering
Jul 11, 2017 09:18AM Ionis Pharmaceuticals (IONS) PT Raised to $62 at BMO Capital; 'NEURO QoL Data Illustrate Inotersen Benefit'
Jun 20, 2017 07:03AM Akcea Therapeutics (AKCA) Launches Proposed IPO with Initial Offering Price of $12 to $14/Share (IONS)
Jun 20, 2017 07:00AM Akcea Therapeutics Launches Proposed Initial Public Offering
May 10, 2017 12:49PM UPDATE: Ionis Pharma (IONS) Defended at BMO Capital - FDA Warning Letter Is Unwarranted
Apr 25, 2017 12:21PM BMO Reiterates Bullish View on Ionis Pharmaceuticals (IONS) as Spinraza Partner Biogen Reports Strong Start
Mar 7, 2017 05:57AM Ionis Pharmaceuticals (IONS) PT Lowered to $59 at BMO Capital on Volanesorsen Data; 'Compliance Rate to 75% from 85%'
Feb 14, 2017 07:43AM BMO Maintains Outperform Rating and $63 PT on Ionis Pharmaceuticals (IONS); Bayer FXI-Rx Expansion
Jan 17, 2017 08:09AM Ionis Pharma (IONS): Cutting PT But Improving Fundamentals - BMO
Jan 6, 2017 06:33AM Ionis Pharma (IONS): Data Confirms Positive Outlook - BMO Capital
Dec 28, 2016 03:55PM Ionis Pharmaceuticals (IONS) PT Raised to $68 at BMO Capital
Dec 27, 2016 06:33AM BMO Capital Sees Ionis Pharma (IONS) and Biogen (BIIB) Trading Higher Following Broad Spinraza Approval
Dec 19, 2016 05:37PM Ionis Pharmaceuticals (IONS) PT Raised to $61 at BMO Capital
Dec 7, 2016 07:00AM Ionis Pharmaceuticals to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
Nov 9, 2016 01:10PM Today's Biotech Upside Could Be Just the Start - BMO Capital (IBB) (XBI)
Nov 7, 2016 12:11PM Streetinsider.com's Hot Lunchtime Reads 11/7: (WATT) (ACIA) (LC) (IONS)
Nov 7, 2016 10:51AM Ionis Pharmaceuticals (IONS) Bullish View Reiterated at BMO Capital Following Spinraza Update
Oct 10, 2016 09:58AM Ionis Pharma (IONS): Data Presentations Increase Confidence - BMO
Oct 6, 2016 06:29AM BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform; To Benefit form Alnylam Failure
Aug 22, 2016 09:41AM Vertex (VRTX), BioMarin (BMRN), Intercept (ICPT), Others Highlighted as Targets at BMO Following PFE/MDVN
Aug 3, 2016 10:41AM Notable Analyst Rating Changes 8/3: (ZNGA) (NMBL) (AVD) Upgraded; (CSIQ) (EQR) (EMR) Downgraded
Aug 1, 2016 12:22PM Ionis Pharmaceuticals (IONS) PT Raised to $40 at BMO Capital
Jul 7, 2016 10:18AM Ionis Pharma (IONS): Benson TTR-Rx Data Support Benefit in FAC and WT - BMO
Jun 6, 2016 06:45AM Ionis Pharma (IONS): Two More SMA Events Could Dampen Interim Look - BMO
May 27, 2016 02:41PM Notable 52-Week Highs and Lows 5/27: (BIG) (VEEV) (ULTA) High; (BIOC) (IONS) (IPCI) Low
May 27, 2016 06:23AM BMO Capital Downgrades Ionis Pharmaceuticals (IONS) to Market Perform
May 26, 2016 09:37AM Ionis Pharma (IONS): CARDIO-TTR Trial Uncertainty as GSK Stops Initiation - BMO
Apr 7, 2016 12:20PM Streetinsider.com's Hot Lunchtime Reads 4/7: (FB) (TSLA) (IONS) (BBBY)
Apr 7, 2016 12:14PM BMO Capital Sees Attractive Entry Point in Ionis (IONS) Amid Sell-Off; Says NEURO-TTR Study Unaffected By Hold
Apr 6, 2016 04:24PM BMO Capital Starts Ionis Pharmaceuticals (IONS) at Outperform
View More Recent Stories View Older Stories